Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

PHX-1149 scheduled to enter clinic for type 2 diabetes in 2005

Dec. 14, 2004

Positive findings from Bentley's phase II study of intranasal insulin in diabetics

Dec. 14, 2004

TLK-199 shows promise in the treatment of MDS

Dec. 14, 2004

Palatin reports new agents for the treatment of obesity

Dec. 13, 2004

Intravenous Boniva submitted for FDA approval

Dec. 13, 2004

Improved glycemic control achieved with insulin glulisine in type 2 diabetes

Dec. 13, 2004

LAB International plans phase II study of GHRH analogue

Dec. 10, 2004

Aryplase submitted for European approval

Dec. 10, 2004

New compounds acting on melanocortin receptors reported by SCRAS

Dec. 10, 2004

FibroGen reports positive findings for oral anemia therapy FG-2216

Dec. 10, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...